Monday, March 17, 2025 | 08:13 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Alkem Laboratories update on USFDA inspection of its facility in St Louis, USA

Image

Capital Market

Receives 8 observations under Form 483

Alkem Laboratories announced that US FDA had conducted an inspection of the Company's manufacturing facility located at St Louis, USA from 14 January, 2019 to 5 February, 2019 in a phased manner.

At the end of inspection, the Company has received Form 483 that contains eight (8) observations. The Company shall submit to US FDA within the stipulated timeline a detailed response with suitable corrective and preventive measures to address the observations.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 06 2019 | 3:18 PM IST

Explore News